title: [Transfusion policy toward a patient with an anti-Cartwright antibody (anti-Yta)].
abstract: We have observed one patient with hepatic cirrhosis showing on her antibody screening an anti-Yta. We studied the 51 Cr-labelled erythrocyte survival using either Yt (a+) and autologous blood red cells. She was transfused two Yt (a+) red blood cell concentrates without any adverse reaction.
authors.affiliation: Servicio de Hematología y Hemoterapia, Hospital Universitario La Fe, Valencia.
authors.forename: F
authors.initials: F
authors.lastname: Arriaga
authors.forename: R
authors.initials: R
authors.lastname: García
authors.forename: M
authors.initials: M
authors.lastname: Guinot
authors.forename: J
authors.initials: J
authors.lastname: de la Rubia
authors.forename: M
authors.initials: M
authors.lastname: García
authors.forename: S
authors.initials: S
authors.lastname: Bonanad
authors.forename: M L
authors.initials: ML
authors.lastname: Marty
mesh_terms: D000368:Aged; D001789:Blood Group Antigens / Q000276:immunology*; D001787:Blood Group Incompatibility; D017707:Erythrocyte Transfusion; D004932:Esophageal and Gastric Varices / Q000150:complications; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000628:therapy; D006801:Humans; D007518:Isoantibodies / Q000097:blood*; D010438:Peptic Ulcer Hemorrhage / Q000150:complications / Q000628:therapy
chemical_list: D001789:Blood Group Antigens; D007518:Isoantibodies
vernacular_title: Actitud transfusional frente a un paciente con un anticuerpo anti-Cartwright (anti-Yta).